Jun 08, 2022 7:00am EDT Societal CDMO Announces Key New Customer Project Within Automated Fill/Finish and Lyophilization Unit at San Diego Facility
Jun 01, 2022 7:00am EDT Societal CDMO Selected By AmyriAD Pharma to Provide Clinical Trials Services to Support Pivotal Phase 3 Program For Alzheimer’s Disease Treatment, AD101
May 17, 2022 7:00am EDT Societal CDMO Unveils “20/80 Second Source Technical Transfer” Service Model, Offering Cost and Time Savings for Pharmaceutical Manufacturing
May 05, 2022 7:00am EDT Societal CDMO Signs Three-Year Manufacturing and Supply Agreement With InfectoPharm for Ritalin LA® in Europe
May 04, 2022 4:05pm EDT Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022
Apr 27, 2022 7:00am EDT Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)
Mar 21, 2022 7:00am EDT Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation